|
|
||||||||
The Journal of Immunology, Vol 144, Issue 3 964-969, Copyright © 1990 by American Association of Immunologists
ARTICLES |
E Munoz, U Beutner, A Zubiaga and BT Huber
Department of Pathology, Tufts University School of Medicine, Boston, MA 02111.
We have investigated the signal transduction pathways mediated by IL-1 in the Th 2 cell line D10.A, and we have made the following findings. Interaction of IL-1 with its receptor leads to the translocation of protein kinase C (PKC) from the cytosol to the membrane, phosphorylation of the 80-kDa protein that is substrate for PKC, as well as an increase in the level of cAMP. In addition, IL-1 induced IL- 5 mRNA expression in these cells. We have established that the IL-5 gene is activated in D10.A cells in response to either phorbol esters or 8-Br cAMP, and that the two agents act as cofactors. IL-1 is able to synergize with phorbol esters and is additive with 8-Br cAMP for IL-5 mRNA expression. There are two possibilities to explain these results: 1) D10.A cells express two types of functional IL-1R, each linked to an independent signal transduction pathway; or 2) these cells have only one kind of IL-1R which, upon ligand interaction, mediates the activation of both the PKC and the adenylate cyclase pathway.
This article has been cited by other articles:
![]() |
N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance Am J Physiol Cell Physiol, August 1, 2004; 287(2): C548 - C557. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Langston, Y. Ke, A. T. Gewirtz, K. E. Dombrowski, and J. A. Kapp Secretion of IL-2 and IFN-{gamma}, But Not IL-4, by Antigen-Specific T Cells Requires Extracellular ATP J. Immunol., March 15, 2003; 170(6): 2962 - 2970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Dinarello Proinflammatory Cytokines Chest, August 1, 2000; 118(2): 503 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Onodera, K. Kaneda, Y. Mizue, Y. Koyama, M. Fujinaga, and J. Nishihira Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis J. Biol. Chem., January 7, 2000; 275(1): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Lee, A. O'Garra, K.-i. Arai, and N. Arai Characterization of cis-Regulatory Elements and Nuclear Factors Conferring Th2-Specific Expression of the IL-5 Gene: A Role for a GATA-Binding Protein J. Immunol., March 1, 1998; 160(5): 2343 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shibuya, D. Robinson, F. Zonin, S. B. Hartley, S. E. Macatonia, C. Somoza, C. A. Hunter, K. M. Murphy, and A. O'Garra IL-1{alpha} and TNF-{alpha} Are Required for IL-12-Induced Development of Th1 Cells Producing High Levels of IFN-{gamma} in BALB/c But Not C57BL/6 Mice J. Immunol., February 15, 1998; 160(4): 1708 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang, H. Hayashi, T. Takii, Y. Mizutani, Y. Inukai, and K. Onozaki Interleukin-1-induced Growth Inhibition of Human Melanoma Cells. INTERLEUKIN-1-INDUCED ANTIZYME EXPRESSION IS RESPONSIBLE FOR ORNITHINE DECARBOXYLASE ACTIVITY DOWN-REGULATION J. Biol. Chem., February 7, 1997; 272(6): 3376 - 3383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Hu, K. Kobayashi, N. Zenda, and T. Shimamura Tumor Necrosis Factor-alpha - and Interleukin-6-Triggered Mast Cell Development From Mouse Spleen Cells Blood, January 15, 1997; 89(2): 526 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Siegel, D.-H. Zhang, P. Ray, and A. Ray Activation of the Interleukin-5 Promoter by cAMP in Murine EL-4 Cells Requires the GATA-3 and CLE0 Elements J. Biol. Chem., October 13, 1995; 270(41): 24548 - 24555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Mathias, A Younes, C. Kan, I Orlow, C Joseph, and R. Kolesnick Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta Science, January 22, 1993; 259(5094): 519 - 522. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |